Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the J.P. Morgan Healthcare Conference on Tuesday, Jan. 14, 2025.

Bernard Zovighian, chief executive officer, is scheduled to present at 11:15 a.m. PT. Scott Ullem, chief financial officer, will also participate in the conference. A live webcast of the presentation will be available on the Edwards Lifesciences investor relations website at http://ir.edwards.com/, with an archived version accessible later the same day.

About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

Edwards, Edwards Lifesciences, and the stylized E logo are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

Media Contact: Amy Hytowitz, 949-250-5070 Investor Contact: Mark Wilterding, 949-250-6826

Edwards Lifesciences (NYSE:EW)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 Edwards Lifesciences 차트를 더 보려면 여기를 클릭.
Edwards Lifesciences (NYSE:EW)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 Edwards Lifesciences 차트를 더 보려면 여기를 클릭.